Phase 1 Study Results of GS-5718, an Oral IRAK4-Inhibitor: Pharmacodynamics of Single and Multiple Doses of GS-5718 in Healthy Subjects

Silke Roedder,Emily Wendt, Chad Burris, Jonathan Nazareon,Grace Park, Phil Pangilinan, Gianna Huang,Anubhav Mathur,James Taylor,Andrew Billin,Franziska Matzkies

ARTHRITIS & RHEUMATOLOGY（2021）

Cited 0|Views10

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined